← Browse by Condition
Medical Condition
advanced gastric carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05620732
Recruiting
Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T
Enrollment
20 pts
Location
China
Sponsor
Shenzhen University General Ho...